Pages
Contractor appointed to build new £15m health services hub for Belper
https://dchs.nhs.uk/news/contractor-appointed-build-new-15m-health-services-hub-belper
A BIG conversation is about to begin… and you’re invited.
Join a generational first big conversation to shape how to improve your wellbeing working in the NHS.
Advice to patients and families during the consultants’ industrial action
https://dchs.nhs.uk/news/advice-patients-and-families-during-consultants-industrial-action
October is AAC Awareness Month!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-aac-awareness-month
2023 Multi-Faith Tours in Derby
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/2023-multi-faith-tours-derby
Patient Group Directions (PGDs)
Patient Group Directions - PGDs provide a legal framework that allows some registered health professionals to supply and/or administer a specified medicine(s) to a pre-defined group of patients, without them having to see a prescriber.
Podiatry - Community Podiatry Service
The community podiatry service provides assessment, diagnosis and treatment to a range of patients with lower limb and foot problems, including; - People with long term conditions such as diabetes, vascular disease, amputees, connective tissue disorders, stroke, Parkinson's disease - People with multiple and complex needs e.g. dementia, falls - People with biomechanical problems e.g. gait /postural problems - People requiring wound care to the foot - People requiring nail surgery - People with severe foot and ankle problems and conditions.
https://dchs.nhs.uk/our-services-and-locations/a-z-list-of-services/community-podiatry
Files
Disclosure Ref 2025113 - Derby & Derbyshire Joint Area Prescribing Committee Traffic Lights Classification .pdf
FOI Disclosure Ref 2025113 relating to Derby & Derbyshire Joint Area Prescribing Committee Traffic Lights Classification
Disclosure Ref 2024236 - Weight loss drug.pdf
Freedom of Information request reference 2024236 relating to GP & A&E appointments and deaths relating to overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs
Disclosure Ref 2024195 - Financial spend on agency staff.pdf
Freedom of information disclosure reference 2024195 relating to financial spend on agency staff for the most recent month
Disclosure Ref 2025183 - Child Exploitation including staff safeguarding training & referrals.pdf
Disclosure Ref 2025183 relating to Child Exploitation including staff safeguarding training & referrals
Final Standard Operating Procedure Safe Staffing Levels and Annual Leave management ISHS October 2025
Disclosure Ref 2024228 - Cost of specialist bariatric equipment.pdf
Freedom of information disclosure relating to spend on specialist bariatric equipment for obese/bariatric patients (patients over 160kg) during the last three financial years and a breakdown of the type of equipment used by the trust and the amounts spent, split between Rental expenditure and Purchased Equipment
Disclosure Ref 2024284 - Medication chain disruptions & incidents.pdf
Freedom of information disclosure relating to medication chain disruptions & incidents due to this
Disclosure Ref 202552 - Clinical Waste Contract.doc
Freedom of information disclosure relating to clinical waste contracts and leads for various services
Disclosure Ref 2025213 - Cyber security incidents, data breaches following cyber incidents & measures in place.doc
Freedom of Information disclosure relating to cyber security incidents, data breaches following cyber incidents & measures in place
Disclosure Ref 2025222 - Thoracoscopy services.doc
Freedom of information relating to thoracoscopy services